Pharma News, 2025

MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study

The investigational agent exhibited superior efficacy vs pembrolizumab in patients with lung cancer, suggesting potential efficacy in kidney cancer.

MetrioPharm’s lead compound, MP1032, has received orphan drug designation (ODD) from the European Medicines Agency (EMA) for treating Duchenne muscular dystrophy (DMD) in chi...

Roche’s Alzheimer’s therapy shows continued benefit

FDA Knew Drugmaker Had Poor Record. It Waited Four Years to Inspect One Factory

GSK's $12 Billion Hengrui Pharma Partnership: A Catalyst for Pipeline Growth and Therapeutic Leadership Beyond 2031

MAIA Biotechnology Reports FDA's Fast Track Designation For Ateganosine

With the introduction of genAI tool Elsa at the FDA in June, the technology is playing a greater role in the medical device review process.

The free trade agreement is expected to reduce regulatory burdens on UK exports to India and boost trade in the pharmaceutical and medical device industries.

Sun Pharma, Lupin, Dr. Reddy's: Pharma stocks may see some pressure tomorrow; here is why

Lantheus Holdings Expands Alzheimer’s Diagnostics Despite Recent Stock Dip

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study